CompletedPhase 2/3

Use of Vasopressin Following the Fontan Operation

United States12 participantsStarted 2016-12

Plain-language summary

The purpose of this pilot study is to prepare for a larger study to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.

Who can participate

Age range18 Months – 7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects between 1.5-7 years old undergoing Fontan operation. Exclusion Criteria: * Patients with a planned fenestrated Fontan. * Patients undergoing revision surgery for failing Fontan. * Evidence of renal insufficiency prior to surgery defined by creatinine \>1 mg/dl. * Planned arch reconstruction at the time of the Fontan procedure

What they're measuring

Chest Tube Drainage

Timeframe: From post operative day 0 through study completion, an average of 1 month

Trial details

NCT IDNCT02975999

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12

Results submitted2023-08-09

View on ClinicalTrials.gov More Pleural Effusion trials